Actively Recruiting
The Surface EMG Biofeedback as an Alternative Therapy to Reduce Chronic Low Back Pain
Led by Amaila Fazal [afazal] · Updated on 2024-09-19
200
Participants Needed
1
Research Sites
95 weeks
Total Duration
On this page
Sponsors
A
Amaila Fazal [afazal]
Lead Sponsor
U
University of Karachi
Collaborating Sponsor
AI-Summary
What this Trial Is About
The prevalence of chronic low back pain (CLBP) among the Pakistani population is reported to be as high as 78% leading towards different physiological and psychosocial alterations with the worst cases suffering from disabilities. CLBP is a multifactorial phenomenon in which age, gender, comorbidities, lifestyle conditions, profession, working hours, and different stressors play their roles in its causation. However, different therapeutic techniques have been determined to reduce CLBP. Thus, this study aimed to assess the effectiveness of the biofeedback surface EMG (sEMG) technique in reducing chronic low back pain among sufferers in the long run.
CONDITIONS
Official Title
The Surface EMG Biofeedback as an Alternative Therapy to Reduce Chronic Low Back Pain
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals who have experienced low back pain continuously for at least the last three months
- Individuals currently seeking care from a healthcare provider for low back pain
- Individuals with an average pain intensity score of 2 or higher on a 0-10 scale over the past week
- Individuals with an average Oswestry Disability Index score of 4 or higher
- Individuals with a State-Trait Anxiety Inventory score of 20 or higher
You will not qualify if you...
- Age younger than 25 or older than 75 years
- Females who are pregnant, breastfeeding, or expect to become pregnant within the next 3 to 6 months
- Individuals diagnosed with any chronic disease
- Individuals diagnosed with neurological disorders including Alzheimer's, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Parkinson's disease, or stroke
- Individuals diagnosed with motor disorders, history of spine surgery, pathologic spinal fractures, avascular necrosis, osteonecrosis, severe osteoarthritis, or hip arthroplasty
- Individuals with active cancer
- Blind individuals
- Individuals with a body mass index greater than 35 kg/m2
- Individuals with clinical depression having a score of 24 or higher on the Center for Epidemiology Depression Scale
- Individuals who have used narcotics or muscle relaxants within 30 days before enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Psychophysiology Lab, University of Karachi
Karachi, Sindh, Pakistan, 75270
Actively Recruiting
Research Team
A
Amaila Fazal
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here